William Allan Corp Has $5.65 Million Position in Zoetis Inc. (NYSE:ZTS)

William Allan Corp grew its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 100.3% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 28,892 shares of the company's stock after buying an additional 14,468 shares during the period. Zoetis makes up 3.4% of William Allan Corp's investment portfolio, making the stock its 10th biggest holding. William Allan Corp's holdings in Zoetis were worth $5,645,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in ZTS. Kennedy Capital Management LLC bought a new stake in shares of Zoetis during the first quarter valued at approximately $883,000. Tidal Investments LLC boosted its stake in Zoetis by 9.8% in the first quarter. Tidal Investments LLC now owns 8,703 shares of the company's stock valued at $1,471,000 after acquiring an additional 776 shares during the last quarter. LRI Investments LLC bought a new position in Zoetis in the first quarter valued at approximately $43,000. Burney Co. boosted its stake in Zoetis by 10.1% in the first quarter. Burney Co. now owns 4,229 shares of the company's stock valued at $716,000 after acquiring an additional 387 shares during the last quarter. Finally, PGGM Investments boosted its stake in Zoetis by 2.7% in the first quarter. PGGM Investments now owns 29,252 shares of the company's stock valued at $4,950,000 after acquiring an additional 779 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ZTS shares. Stifel Nicolaus raised their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a "buy" rating in a research note on Wednesday, September 18th. BTIG Research lifted their price target on shares of Zoetis from $220.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday, August 12th. JPMorgan Chase & Co. lifted their price target on shares of Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. Piper Sandler lifted their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 14th. Finally, Argus upgraded shares of Zoetis to a "strong-buy" rating in a report on Friday, August 9th. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Buy" and an average target price of $221.44.

Zoetis Stock Down 0.8 %

ZTS stock traded down $1.49 during midday trading on Friday, hitting $175.25. The company's stock had a trading volume of 1,543,413 shares, compared to its average volume of 2,545,742. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The company's fifty day moving average price is $184.18 and its 200 day moving average price is $180.78. The stock has a market capitalization of $79.07 billion, a P/E ratio of 33.22, a PEG ratio of 2.71 and a beta of 0.90.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter last year, the firm posted $1.36 EPS. The company's quarterly revenue was up 11.6% on a year-over-year basis. As a group, equities research analysts predict that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be issued a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis's payout ratio is 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.